Stock-Based Compensation

3 Months Ended

Mar. 29, 2026

Share-Based Payment Arrangement [Abstract]

The following table summarizes the Company's stock-based compensation expense included as a component of general and administrative expenses in the Condensed Consolidated Statements of Comprehensive Income:



	Three Months Ended
	March 29, 2026		March 30, 2025
	(In millions)
Equity classified awards expense	$	4.1	$	3.4
Liability classified awards expense	0.7		0.3
Total stock-based compensation expense	$	4.8	$	3.7

As of March 29, 2026, total unrecognized compensation cost related to restricted stock awards and restricted stock units of $22.1 million and $0.6 million related to stock options is expected to be recognized over a weighted average period of approximately 1.5 years for restricted stock and restricted stock units and 0.8 years for stock options.

A significant majority of the Company’s equity grants occur in the first quarter of its fiscal year. Accordingly, during the three months ended March 29, 2026, the Company granted approximately 339,000 restricted stock and 49,000 restricted stock unit awards with a weighted average grant date fair value of $30.98 and $30.96, respectively. The Company did not grant any options in this period.

For the three months ended March 29, 2026 and 2025, the Company recorded expense of $0.7 million and $0.3 million, respectively, related to liability classified awards. As of March 29, 2026 and December 28, 2025, a liability of $2.1 million and $3.3 million, respectively, was recorded as Other non-current liabilities on the Condensed Consolidated Balance Sheets.